story of the week
Neoadjuvant Atezolizumab Plus Chemotherapy for Gastric and Gastroesophageal Junction Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Nat. Med. 2024 Jan 08;[EPub Ahead of Print], YL Verschoor, J van de Haar, JG van den Berg, JW van Sandick, LL Kodach, JM van Dieren, S Balduzzi, C Grootscholten, ME IJsselsteijn, AAFA Veenhof, KJ Hartemink, MA Vollebergh, A Jurdi, S Sharma, E Spickard, EC Owers, A Bartels-Rutten, P den Hartog, NFCC de Miranda, ME van Leerdam, JBAG Haanen, TN Schumacher, EE Voest, M ChalabiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.